Recent developments with Recursion Pharmaceuticals Inc (RXRX) have led to the company’s beta value being reach 0.95 cents.
On Thursday, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) remained unchanged from the previous day of trading 3.38% from the last session, before settling in for the